期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Limited previous studies focused on the death and progression risk stratification of colorectal cancer (CRC) lung metastasis patients. The aim of this......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Drug resistance represents a major obstacle in cancer management, and the mechanisms underlying stress adaptation of cancer cells in response to thera......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Background: Lung adenocarcinoma (LUAD) is the leading cause of death worldwide. However, the roles of long noncoding RNAs (lncRNAs) hijacked by super-......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Background Circular RNAs (circRNAs) represent a novel type of regulatory RNA characterized by high evolutionary conservation and stability. CircRNAs a......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
High-grade B-cell lymphoma with translocations involving MYC and BCL2 or BCL6, usually referred to as double hit lymphoma (DHL), is an aggressive hema......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Disrupting the methylation of telomeric silencing 1-like (DOT1L)-mediated histone H3 lysine 79 has been implicated in MLL fusion-mediated leukemogenes......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Cancer is a top-ranked life-threatening disease with intratumor heterogeneity. Tumor heterogeneity is associated with metastasis, relapse, and therapy......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstein-Barr virus (EBV......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Relapsed or refractory (R/R) acute myeloid leukemia (AML) has a poor prognosis. In this study, we evaluated chimeric antigen receptor (CAR) T cell the......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the preferential options for advanced non-small cell lung cancer (NSCLC) p......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Cancer microenvironment is critical for tumorigenesis and cancer progression. The extracellular matrix (ECM) interacts with tumor and stromal cells to......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the worst prognoses, with no targeted therapeutic strategies curr......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Hypoxia, a common feature of the tumor microenvironment in various types of cancers, weakens cytotoxic T cell function and causes recruitment of regul......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
The discovery of immune checkpoint inhibitors (ICIs) has now been universally acknowledged as a significant breakthrough in tumor therapy after the ta......
期刊： JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1)
Emerging evidence indicates that the detection and clearance of cancer cells via phagocytosis induced by innate immune checkpoints play significant ro......
